Cargando…

Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis

Background: Chronic drug-induced liver injury (DILI) occurs in up to 20% of all DILI patients. It presents a chronic pattern with persistent or relapsed episodes and may even progress to cirrhosis. However, its underlying development mechanism is poorly understood. Aims: To find serum metabolite sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shuai-shuai, Huang, Ying, Guo, Yu-ming, Li, Shan-shan, Shi, Zhuo, Niu, Ming, Zou, Zheng-sheng, Xiao, Xiao-he, Wang, Jia-bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039323/ https://www.ncbi.nlm.nih.gov/pubmed/33855035 http://dx.doi.org/10.3389/fmed.2021.640799

Ejemplares similares

Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis
por: Li, Shan-shan, et al.
Publicado: (2021)

Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to Polygonum multiflorum: A Cross-Sectional Cohort Study
por: Huang, Ying, et al.
Publicado: (2020)

Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol‐Associated Liver Cirrhosis
por: Huang, Ying, et al.
Publicado: (2021)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Age-Associated Risk of Liver-Related Adverse Drug Reactions
por: Han, Yan-zhong, et al.
Publicado: (2022)

Metabolomic Analysis Uncovers Lipid and Amino Acid Metabolism Disturbance During the Development of Ascites in Alcoholic Liver Disease
por: Cheng, Cheng, et al.
Publicado: (2022)

Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics
por: Tu, Can, et al.
Publicado: (2021)

Enlargements of the Liver.—IV: Cirrhosis of the Liver
Publicado: (1910)

A New Scoring System for Predicting In-hospital Death in Patients Having Liver Cirrhosis With Esophageal Varices
por: Xu, Fengshuo, et al.
Publicado: (2021)

Prognostic Value of Serum Exosomal AHCY Expression in Hepatitis B-Induced Liver Cirrhosis
por: Tong, Ling, et al.
Publicado: (2021)

Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
por: Xu, Manman, et al.
Publicado: (2021)

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

Enlargements of the Liver.—V: Cirrhosis (Continued)
Publicado: (1910)

Enlargements of the Liver.—VI: Cirrhosis (concluded)
Publicado: (1910)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Serum metabolic signatures for acute pulmonary embolism identified by untargeted metabolomics
por: Xie, Ming, et al.
Publicado: (2023)

Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study
por: Wang, Hong-Liang, et al.
Publicado: (2021)

Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study
por: Dong, Qin, et al.
Publicado: (2015)

Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients
por: Lou, Yan, et al.
Publicado: (2021)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
por: Sauerbruch, Tilman, et al.
Publicado: (2023)

Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury
por: Ma, Zhenhua, et al.
Publicado: (2019)

Contrast-induced Acute Kidney Injury in Patients with Liver Cirrhosis: A Retrospective Analysis
por: Ul Abideen, Zain, et al.
Publicado: (2018)

LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis
por: Pan, Hong Y., et al.
Publicado: (2021)

Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
por: Jagdish, Rakesh Kumar, et al.
Publicado: (2023)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis
por: Li, Chun-Yu, et al.
Publicado: (2016)

Investigation Into the Risk Factors Related to In-stent Restenosis in Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Within 2 Years After the First Drug-Eluting Stent Implantation
por: Yi, Ming, et al.
Publicado: (2022)

Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV
por: Zhang, Hang, et al.
Publicado: (2009)

A Nomogram for Predicting Portal Hypertensive Gastropathy in Patients With Liver Cirrhosis: A Retrospective Analysis
por: Wang, WenSheng, et al.
Publicado: (2022)

Frequency of Venous Thromboembolism in Patients with Liver Cirrhosis
por: Omer Sultan, Muhammad, et al.
Publicado: (2020)

Uncertainty of Liver Cirrhosis Diagnosis and Use of Elastography
por: Aloise, Daniel M, et al.
Publicado: (2021)

Hereditary Spherocytosis With Liver Transplantation After Cirrhosis: A Case Report
por: Yang, Xueliang, et al.
Publicado: (2022)

A Meta-analysis of the Value of vWF in the Diagnosis of Liver Cirrhosis with Portal Hypertension
por: Ding, Xiang-Chun, et al.
Publicado: (2018)

Correlation between serum cytokines and clinicopathological features in patients with drug-induced liver injury
por: Zhang, Yu, et al.
Publicado: (2022)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
por: Xie, Zhi-Qin, et al.
Publicado: (2021)

The Programmed Cell Death of Macrophages, Endothelial Cells, and Tubular Epithelial Cells in Sepsis-AKI
por: Li, Chao, et al.
Publicado: (2021)

Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives
por: Gülcicegi, Dilan Elcin, et al.
Publicado: (2023)

Circulating Extracellular Vesicles and Their miR “Barcode” Differentiate Alcohol Drinkers With Liver Injury and Those Without Liver Injury in Severe Trauma Patients
por: Eguchi, Akiko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4527pe6kav9h6v2vd3h3nkb6ik